

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.97043673 |
| 2 | negative regulation of cell killing (GO:0031342) | 5.97043673 |
| 3 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.22174261 |
| 4 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.22174261 |
| 5 | modulation by symbiont of host immune response (GO:0052553) | 5.22174261 |
| 6 | positive regulation by symbiont of host defense response (GO:0052509) | 5.22174261 |
| 7 | modulation by symbiont of host defense response (GO:0052031) | 5.22174261 |
| 8 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.22174261 |
| 9 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.01941219 |
| 10 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.81635498 |
| 11 | detection of molecule of bacterial origin (GO:0032490) | 4.47846992 |
| 12 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.40008196 |
| 13 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.29731062 |
| 14 | detection of other organism (GO:0098543) | 4.22979593 |
| 15 | response to peptidoglycan (GO:0032494) | 4.09966270 |
| 16 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.07911153 |
| 17 | response to interleukin-15 (GO:0070672) | 4.06811500 |
| 18 | macrophage activation involved in immune response (GO:0002281) | 4.02101070 |
| 19 | low-density lipoprotein particle clearance (GO:0034383) | 4.01167474 |
| 20 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.00959937 |
| 21 | cellular extravasation (GO:0045123) | 3.99921059 |
| 22 | detection of external biotic stimulus (GO:0098581) | 3.93236071 |
| 23 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.83887002 |
| 24 | detection of bacterium (GO:0016045) | 3.83311586 |
| 25 | neutrophil mediated immunity (GO:0002446) | 3.79665839 |
| 26 | fatty acid transmembrane transport (GO:1902001) | 3.72244571 |
| 27 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.67729546 |
| 28 | response to host immune response (GO:0052572) | 3.65278243 |
| 29 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.65278243 |
| 30 | carnitine shuttle (GO:0006853) | 3.63865524 |
| 31 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.61473295 |
| 32 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 3.57414399 |
| 33 | leukocyte aggregation (GO:0070486) | 3.57166905 |
| 34 | cellular response to interleukin-15 (GO:0071350) | 3.55908583 |
| 35 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.54580820 |
| 36 | response to muramyl dipeptide (GO:0032495) | 3.54036676 |
| 37 | alpha-linolenic acid metabolic process (GO:0036109) | 3.52634034 |
| 38 | detection of biotic stimulus (GO:0009595) | 3.47491099 |
| 39 | response to host (GO:0075136) | 3.42833492 |
| 40 | response to host defenses (GO:0052200) | 3.42833492 |
| 41 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.42833492 |
| 42 | germinal center formation (GO:0002467) | 3.41997289 |
| 43 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.40143813 |
| 44 | lysine metabolic process (GO:0006553) | 3.37823535 |
| 45 | lysine catabolic process (GO:0006554) | 3.37823535 |
| 46 | urea cycle (GO:0000050) | 3.35454851 |
| 47 | urea metabolic process (GO:0019627) | 3.35454851 |
| 48 | respiratory burst (GO:0045730) | 3.33451066 |
| 49 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.30511157 |
| 50 | regulation of necroptotic process (GO:0060544) | 3.28122498 |
| 51 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.25878739 |
| 52 | dosage compensation (GO:0007549) | 3.24900538 |
| 53 | neutrophil activation involved in immune response (GO:0002283) | 3.24579874 |
| 54 | mitotic chromosome condensation (GO:0007076) | 3.23333059 |
| 55 | 2-oxoglutarate metabolic process (GO:0006103) | 3.19012739 |
| 56 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.17534358 |
| 57 | neutrophil activation (GO:0042119) | 3.17084920 |
| 58 | regulation of hippo signaling (GO:0035330) | 3.14949846 |
| 59 | negative regulation of T cell mediated immunity (GO:0002710) | 3.13992044 |
| 60 | B cell receptor signaling pathway (GO:0050853) | 3.12924441 |
| 61 | regulation of sequestering of triglyceride (GO:0010889) | 3.12912767 |
| 62 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.12601276 |
| 63 | negative regulation of interleukin-12 production (GO:0032695) | 3.11609767 |
| 64 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.10684016 |
| 65 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.08742515 |
| 66 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.08742515 |
| 67 | plasma lipoprotein particle clearance (GO:0034381) | 3.07207608 |
| 68 | myeloid leukocyte mediated immunity (GO:0002444) | 3.02870102 |
| 69 | cytoplasmic mRNA processing body assembly (GO:0033962) | 3.02721658 |
| 70 | valine metabolic process (GO:0006573) | 2.98919488 |
| 71 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.97475250 |
| 72 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.96509086 |
| 73 | ethanol oxidation (GO:0006069) | 2.92912785 |
| 74 | positive regulation of lipid storage (GO:0010884) | 2.92394021 |
| 75 | phospholipid homeostasis (GO:0055091) | 2.91783473 |
| 76 | macrophage activation (GO:0042116) | 2.91125663 |
| 77 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.90606396 |
| 78 | regulation of cholesterol storage (GO:0010885) | 2.90250246 |
| 79 | negative regulation of cell size (GO:0045792) | 2.88758406 |
| 80 | paraxial mesoderm development (GO:0048339) | 2.87632691 |
| 81 | cardiac myofibril assembly (GO:0055003) | 2.87320201 |
| 82 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.86020734 |
| 83 | negative regulation of necroptotic process (GO:0060546) | 2.85483542 |
| 84 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.85256884 |
| 85 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.84079952 |
| 86 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.84079952 |
| 87 | nitrogen cycle metabolic process (GO:0071941) | 2.82715735 |
| 88 | regulation of cholesterol homeostasis (GO:2000188) | 2.81427352 |
| 89 | negative thymic T cell selection (GO:0045060) | 2.81004697 |
| 90 | negative regulation of B cell mediated immunity (GO:0002713) | 2.79164627 |
| 91 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 2.79164627 |
| 92 | microglial cell activation (GO:0001774) | 2.78942642 |
| 93 | granulocyte activation (GO:0036230) | 2.78775759 |
| 94 | positive T cell selection (GO:0043368) | 2.78425392 |
| 95 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.78394893 |
| 96 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.77900572 |
| 97 | cellular ketone body metabolic process (GO:0046950) | 2.77074275 |
| 98 | complement activation, alternative pathway (GO:0006957) | 2.76705703 |
| 99 | fibroblast migration (GO:0010761) | 2.75254267 |
| 100 | positive regulation of fatty acid oxidation (GO:0046321) | 2.74624438 |
| 101 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.73758325 |
| 102 | histone H2A monoubiquitination (GO:0035518) | 2.73448535 |
| 103 | embryonic process involved in female pregnancy (GO:0060136) | 2.73395461 |
| 104 | cysteine metabolic process (GO:0006534) | 2.70647770 |
| 105 | negative T cell selection (GO:0043383) | 2.70009004 |
| 106 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.69569329 |
| 107 | negative regulation of fibrinolysis (GO:0051918) | 2.69167138 |
| 108 | negative regulation of myotube differentiation (GO:0010832) | 2.68616292 |
| 109 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.68225669 |
| 110 | regulation of protein activation cascade (GO:2000257) | 2.65463259 |
| 111 | pentose-phosphate shunt (GO:0006098) | 2.63055909 |
| 112 | histone H3-K36 demethylation (GO:0070544) | 2.62894063 |
| 113 | skeletal muscle adaptation (GO:0043501) | 2.62484243 |
| 114 | sarcomere organization (GO:0045214) | 2.61994710 |
| 115 | positive thymic T cell selection (GO:0045059) | 2.61934898 |
| 116 | glyoxylate metabolic process (GO:0046487) | 2.60345905 |
| 117 | pre-miRNA processing (GO:0031054) | 2.59571802 |
| 118 | positive regulation of interleukin-17 production (GO:0032740) | 2.59187524 |
| 119 | regulation of fatty acid oxidation (GO:0046320) | 2.58801954 |
| 120 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.57333669 |
| 121 | kynurenine metabolic process (GO:0070189) | 2.57270405 |
| 122 | amino-acid betaine metabolic process (GO:0006577) | 2.57249118 |
| 123 | negative regulation of adaptive immune response (GO:0002820) | 2.57128436 |
| 124 | carnitine transmembrane transport (GO:1902603) | 2.56759334 |
| 125 | serine family amino acid catabolic process (GO:0009071) | 2.55915674 |
| 126 | negative regulation of histone methylation (GO:0031061) | 2.55639458 |
| 127 | T cell selection (GO:0045058) | 2.54255870 |
| 128 | negative regulation of retinoic acid receptor signaling pathway (GO:0048387) | 2.54155400 |
| 129 | positive regulation of lipid catabolic process (GO:0050996) | 2.54088156 |
| 130 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.54004980 |
| 131 | negative regulation of fatty acid metabolic process (GO:0045922) | 2.53266658 |
| 132 | acetyl-CoA metabolic process (GO:0006084) | 2.53161588 |
| 133 | natural killer cell differentiation (GO:0001779) | 2.53145623 |
| 134 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.52789894 |
| 135 | regulation of complement activation (GO:0030449) | 2.52215018 |
| 136 | growth hormone receptor signaling pathway (GO:0060396) | 2.52085124 |
| 137 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.51960549 |
| 138 | tricarboxylic acid metabolic process (GO:0072350) | 2.51254129 |
| 139 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.51237062 |
| 140 | fatty acid homeostasis (GO:0055089) | 2.50411397 |
| 141 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.50016659 |
| 142 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.49634942 |
| 143 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.49154463 |
| 144 | L-phenylalanine metabolic process (GO:0006558) | 2.49154463 |
| 145 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.48716722 |
| 146 | histone lysine demethylation (GO:0070076) | 2.48383736 |
| 147 | regulation of sister chromatid cohesion (GO:0007063) | 2.48297220 |
| 148 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.47408431 |
| 149 | positive regulation of histone deacetylation (GO:0031065) | 2.45667451 |
| 150 | cardiac muscle cell development (GO:0055013) | 2.45280165 |
| 151 | ketone body metabolic process (GO:1902224) | 2.45243023 |
| 152 | glycine metabolic process (GO:0006544) | 2.45179092 |
| 153 | NADPH regeneration (GO:0006740) | 2.45069377 |
| 154 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.45027671 |
| 155 | cellular response to type I interferon (GO:0071357) | 2.44942213 |
| 156 | type I interferon signaling pathway (GO:0060337) | 2.44942213 |
| 157 | creatine metabolic process (GO:0006600) | 2.44592131 |
| 158 | defense response to protozoan (GO:0042832) | 2.43896820 |
| 159 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 2.43500698 |
| 160 | regulation of triglyceride catabolic process (GO:0010896) | 2.43425145 |
| 161 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.43226743 |
| 162 | L-phenylalanine catabolic process (GO:0006559) | 2.43226743 |
| 163 | regulation of mast cell degranulation (GO:0043304) | 2.43003722 |
| 164 | regulation of B cell differentiation (GO:0045577) | 2.42998901 |
| 165 | response to type I interferon (GO:0034340) | 2.42975523 |
| 166 | RNA stabilization (GO:0043489) | 2.42912697 |
| 167 | mRNA stabilization (GO:0048255) | 2.42912697 |
| 168 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.42503045 |
| 169 | protein carboxylation (GO:0018214) | 2.42082089 |
| 170 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.42082089 |
| 171 | negative regulation of interleukin-6 production (GO:0032715) | 2.41680298 |
| 172 | amino-acid betaine transport (GO:0015838) | 2.41620910 |
| 173 | carnitine transport (GO:0015879) | 2.41620910 |
| 174 | histone H4 deacetylation (GO:0070933) | 2.41452087 |
| 175 | striated muscle atrophy (GO:0014891) | 2.39900069 |
| 176 | positive regulation of glycogen biosynthetic process (GO:0045725) | 2.39414625 |
| 177 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.37779450 |
| 178 | myofibril assembly (GO:0030239) | 2.36457947 |
| 179 | carnitine metabolic process (GO:0009437) | 2.36029805 |
| 180 | one-carbon metabolic process (GO:0006730) | 2.35268406 |
| 181 | ethanol metabolic process (GO:0006067) | 2.35144261 |
| 182 | histone demethylation (GO:0016577) | 2.35034997 |
| 183 | sulfur amino acid catabolic process (GO:0000098) | 2.34081143 |
| 184 | negative regulation of cholesterol transport (GO:0032375) | 2.33451778 |
| 185 | negative regulation of sterol transport (GO:0032372) | 2.33451778 |
| 186 | cardiac cell development (GO:0055006) | 2.33378008 |
| 187 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.33069281 |
| 188 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 cla | 2.32600074 |
| 189 | regulation of SMAD protein import into nucleus (GO:0060390) | 2.32541119 |
| 190 | fatty acid beta-oxidation (GO:0006635) | 2.32493865 |
| 191 | regulation of gamma-delta T cell activation (GO:0046643) | 2.32491841 |
| 192 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 2.30587293 |
| 193 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.29008880 |
| 194 | protein demethylation (GO:0006482) | 2.27375838 |
| 195 | protein dealkylation (GO:0008214) | 2.27375838 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.63233370 |
| 2 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 4.55523034 |
| 3 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 4.03092274 |
| 4 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.66516225 |
| 5 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.40991010 |
| 6 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.34242909 |
| 7 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.31811278 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.21273774 |
| 9 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.19485011 |
| 10 | MYC_22102868_ChIP-Seq_BL_Human | 2.79092217 |
| 11 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.67675216 |
| 12 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.67487173 |
| 13 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.66813091 |
| 14 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.60970764 |
| 15 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.54451236 |
| 16 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.54403594 |
| 17 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.23379080 |
| 18 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.22677605 |
| 19 | SPI1_23127762_ChIP-Seq_K562_Human | 2.21535836 |
| 20 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.20011264 |
| 21 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.18101993 |
| 22 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.14916346 |
| 23 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.13635852 |
| 24 | MYB_26560356_Chip-Seq_TH2_Human | 2.12748204 |
| 25 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.03699197 |
| 26 | MAF_26560356_Chip-Seq_TH2_Human | 2.02819206 |
| 27 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.02605109 |
| 28 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.01150931 |
| 29 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.97850888 |
| 30 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.91587244 |
| 31 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.90580775 |
| 32 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.89416895 |
| 33 | MYB_26560356_Chip-Seq_TH1_Human | 1.88801015 |
| 34 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.85387308 |
| 35 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.83765371 |
| 36 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.83761625 |
| 37 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.80617222 |
| 38 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.78851319 |
| 39 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.78470623 |
| 40 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.78103099 |
| 41 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.76610537 |
| 42 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.76574686 |
| 43 | GATA1_22025678_ChIP-Seq_K562_Human | 1.76006966 |
| 44 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.73387276 |
| 45 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.71119273 |
| 46 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.70744705 |
| 47 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.68976466 |
| 48 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.66038697 |
| 49 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.64487429 |
| 50 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.60571587 |
| 51 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.58273257 |
| 52 | ATF3_27146783_Chip-Seq_COLON_Human | 1.55269686 |
| 53 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.52550218 |
| 54 | UTX_26944678_Chip-Seq_JUKART_Human | 1.51508276 |
| 55 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.51185825 |
| 56 | MAF_26560356_Chip-Seq_TH1_Human | 1.48814996 |
| 57 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.48786249 |
| 58 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.47956937 |
| 59 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.46992122 |
| 60 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.46493718 |
| 61 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.45930211 |
| 62 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.44093754 |
| 63 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.43278498 |
| 64 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.40403196 |
| 65 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.40289655 |
| 66 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.39553660 |
| 67 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.38777904 |
| 68 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.38741919 |
| 69 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.37600095 |
| 70 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.35170237 |
| 71 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.34201054 |
| 72 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.32962442 |
| 73 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.32736067 |
| 74 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.31637498 |
| 75 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.30409870 |
| 76 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.29948872 |
| 77 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.29544122 |
| 78 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.29369010 |
| 79 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.27120974 |
| 80 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.27083359 |
| 81 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.26497081 |
| 82 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.25306335 |
| 83 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.24039277 |
| 84 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.23331632 |
| 85 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.22850202 |
| 86 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.22371338 |
| 87 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.22084961 |
| 88 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.20696191 |
| 89 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.19384202 |
| 90 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.19144401 |
| 91 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.19124220 |
| 92 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.18705639 |
| 93 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.18705639 |
| 94 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.18355447 |
| 95 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.15890620 |
| 96 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15263117 |
| 97 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.14993864 |
| 98 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 1.14692946 |
| 99 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.14666763 |
| 100 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.14637871 |
| 101 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.14519192 |
| 102 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.13945738 |
| 103 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.13507702 |
| 104 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.12446718 |
| 105 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.12440014 |
| 106 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.09980442 |
| 107 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.09378359 |
| 108 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.08778909 |
| 109 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.08636646 |
| 110 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.08276452 |
| 111 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.07969548 |
| 112 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.06818959 |
| 113 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.06662895 |
| 114 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.06657250 |
| 115 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.06344130 |
| 116 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.06073357 |
| 117 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.05988456 |
| 118 | GATA1_19941826_ChIP-Seq_K562_Human | 1.05282439 |
| 119 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.05191319 |
| 120 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.04432958 |
| 121 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.04148871 |
| 122 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.04097339 |
| 123 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.03798221 |
| 124 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.03356704 |
| 125 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.03269914 |
| 126 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.03113896 |
| 127 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.02570873 |
| 128 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.02508853 |
| 129 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.02460673 |
| 130 | KDM2B_26808549_Chip-Seq_K562_Human | 1.02443718 |
| 131 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.02183363 |
| 132 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 1.01658777 |
| 133 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.01616039 |
| 134 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.01049761 |
| 135 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.01039939 |
| 136 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.00913040 |
| 137 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.00912908 |
| 138 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.99911390 |
| 139 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.99265242 |
| 140 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.97748466 |
| 141 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97635871 |
| 142 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.96121974 |
| 143 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.95904637 |
| 144 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.95687333 |
| 145 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.95644353 |
| 146 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.95398205 |
| 147 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.95276646 |
| 148 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.93465788 |
| 149 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.93360027 |
| 150 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.92201072 |
| 151 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.91971166 |
| 152 | * NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 0.91287738 |
| 153 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.91160500 |
| 154 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.90877914 |
| 155 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.90322716 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 4.20205475 |
| 2 | MP0003705_abnormal_hypodermis_morpholog | 3.56578510 |
| 3 | MP0008260_abnormal_autophagy | 3.20389483 |
| 4 | MP0002139_abnormal_hepatobiliary_system | 2.91726375 |
| 5 | MP0005360_urolithiasis | 2.74533112 |
| 6 | MP0003646_muscle_fatigue | 2.72769097 |
| 7 | MP0001835_abnormal_antigen_presentation | 2.57722251 |
| 8 | MP0004185_abnormal_adipocyte_glucose | 2.51625910 |
| 9 | MP0009840_abnormal_foam_cell | 2.50842566 |
| 10 | MP0009278_abnormal_bone_marrow | 2.45633255 |
| 11 | MP0002419_abnormal_innate_immunity | 2.28808840 |
| 12 | MP0005365_abnormal_bile_salt | 2.27799199 |
| 13 | MP0004130_abnormal_muscle_cell | 2.24153796 |
| 14 | MP0003763_abnormal_thymus_physiology | 2.21023220 |
| 15 | MP0001800_abnormal_humoral_immune | 2.13778730 |
| 16 | MP0000685_abnormal_immune_system | 2.02583945 |
| 17 | MP0005025_abnormal_response_to | 1.98906392 |
| 18 | MP0005666_abnormal_adipose_tissue | 1.98708328 |
| 19 | MP0005076_abnormal_cell_differentiation | 1.98574635 |
| 20 | MP0003303_peritoneal_inflammation | 1.98087788 |
| 21 | MP0002837_dystrophic_cardiac_calcinosis | 1.92949551 |
| 22 | MP0005000_abnormal_immune_tolerance | 1.92624087 |
| 23 | MP0000569_abnormal_digit_pigmentation | 1.92232760 |
| 24 | MP0002723_abnormal_immune_serum | 1.86050520 |
| 25 | MP0002420_abnormal_adaptive_immunity | 1.84078831 |
| 26 | MP0002396_abnormal_hematopoietic_system | 1.80182920 |
| 27 | MP0001819_abnormal_immune_cell | 1.80171468 |
| 28 | MP0005451_abnormal_body_composition | 1.79578227 |
| 29 | MP0002009_preneoplasia | 1.79483745 |
| 30 | MP0001790_abnormal_immune_system | 1.77666633 |
| 31 | MP0005387_immune_system_phenotype | 1.77666633 |
| 32 | MP0010352_gastrointestinal_tract_polyps | 1.75725505 |
| 33 | MP0005085_abnormal_gallbladder_physiolo | 1.74342638 |
| 34 | MP0002452_abnormal_antigen_presenting | 1.69700277 |
| 35 | MP0004510_myositis | 1.68984633 |
| 36 | MP0004087_abnormal_muscle_fiber | 1.67367223 |
| 37 | MP0002398_abnormal_bone_marrow | 1.64935231 |
| 38 | MP0000733_abnormal_muscle_development | 1.64710907 |
| 39 | MP0000703_abnormal_thymus_morphology | 1.54883485 |
| 40 | MP0010329_abnormal_lipoprotein_level | 1.53141458 |
| 41 | MP0004084_abnormal_cardiac_muscle | 1.53007368 |
| 42 | MP0000465_gastrointestinal_hemorrhage | 1.52889440 |
| 43 | MP0002405_respiratory_system_inflammati | 1.52413345 |
| 44 | MP0003806_abnormal_nucleotide_metabolis | 1.51645009 |
| 45 | MP0004381_abnormal_hair_follicle | 1.50976033 |
| 46 | MP0009785_altered_susceptibility_to | 1.50940672 |
| 47 | MP0003252_abnormal_bile_duct | 1.50658542 |
| 48 | MP0001533_abnormal_skeleton_physiology | 1.50188474 |
| 49 | MP0010630_abnormal_cardiac_muscle | 1.48170972 |
| 50 | MP0000716_abnormal_immune_system | 1.47739558 |
| 51 | MP0000749_muscle_degeneration | 1.46054781 |
| 52 | * MP0000609_abnormal_liver_physiology | 1.44551262 |
| 53 | MP0003656_abnormal_erythrocyte_physiolo | 1.43212933 |
| 54 | MP0002653_abnormal_ependyma_morphology | 1.42756406 |
| 55 | MP0010234_abnormal_vibrissa_follicle | 1.40813466 |
| 56 | MP0005671_abnormal_response_to | 1.40068575 |
| 57 | MP0002722_abnormal_immune_system | 1.39532700 |
| 58 | MP0003566_abnormal_cell_adhesion | 1.38049601 |
| 59 | MP0003183_abnormal_peptide_metabolism | 1.36847206 |
| 60 | MP0000750_abnormal_muscle_regeneration | 1.35322889 |
| 61 | MP0002132_abnormal_respiratory_system | 1.34126717 |
| 62 | MP0000751_myopathy | 1.31693255 |
| 63 | MP0000689_abnormal_spleen_morphology | 1.31547807 |
| 64 | MP0002269_muscular_atrophy | 1.29853742 |
| 65 | MP0003828_pulmonary_edema | 1.27030078 |
| 66 | MP0005083_abnormal_biliary_tract | 1.26204859 |
| 67 | MP0001849_ear_inflammation | 1.25584020 |
| 68 | MP0005248_abnormal_Harderian_gland | 1.23069516 |
| 69 | MP0004808_abnormal_hematopoietic_stem | 1.22193819 |
| 70 | MP0004484_altered_response_of | 1.21202759 |
| 71 | * MP0003221_abnormal_cardiomyocyte_apopto | 1.20171451 |
| 72 | MP0002429_abnormal_blood_cell | 1.19951901 |
| 73 | MP0005330_cardiomyopathy | 1.19502822 |
| 74 | MP0003172_abnormal_lysosome_physiology | 1.19395520 |
| 75 | MP0004883_abnormal_blood_vessel | 1.15973586 |
| 76 | * MP0001730_embryonic_growth_arrest | 1.15122400 |
| 77 | MP0005023_abnormal_wound_healing | 1.15065264 |
| 78 | MP0003300_gastrointestinal_ulcer | 1.14993470 |
| 79 | MP0008961_abnormal_basal_metabolism | 1.13967930 |
| 80 | MP0005375_adipose_tissue_phenotype | 1.13746396 |
| 81 | MP0006082_CNS_inflammation | 1.13552433 |
| 82 | MP0000858_altered_metastatic_potential | 1.12589983 |
| 83 | MP0010155_abnormal_intestine_physiology | 1.12155193 |
| 84 | MP0002106_abnormal_muscle_physiology | 1.11173309 |
| 85 | MP0005670_abnormal_white_adipose | 1.10771688 |
| 86 | MP0003436_decreased_susceptibility_to | 1.10590611 |
| 87 | MP0004036_abnormal_muscle_relaxation | 1.07781144 |
| 88 | MP0001845_abnormal_inflammatory_respons | 1.07383484 |
| 89 | MP0009672_abnormal_birth_weight | 1.06900799 |
| 90 | MP0002127_abnormal_cardiovascular_syste | 1.06068981 |
| 91 | MP0003567_abnormal_fetal_cardiomyocyte | 1.04646202 |
| 92 | MP0000747_muscle_weakness | 1.03336178 |
| 93 | MP0004858_abnormal_nervous_system | 1.03280321 |
| 94 | MP0003191_abnormal_cellular_cholesterol | 1.02869372 |
| 95 | MP0003077_abnormal_cell_cycle | 1.02693950 |
| 96 | MP0001851_eye_inflammation | 1.02179045 |
| 97 | MP0002971_abnormal_brown_adipose | 1.01804804 |
| 98 | MP0003693_abnormal_embryo_hatching | 1.01533337 |
| 99 | MP0000767_abnormal_smooth_muscle | 1.00645168 |
| 100 | MP0000759_abnormal_skeletal_muscle | 0.99560605 |
| 101 | MP0005464_abnormal_platelet_physiology | 0.99169183 |
| 102 | * MP0002088_abnormal_embryonic_growth/wei | 0.97074984 |
| 103 | * MP0001672_abnormal_embryogenesis/_devel | 0.96547784 |
| 104 | * MP0005380_embryogenesis_phenotype | 0.96547784 |
| 105 | MP0001915_intracranial_hemorrhage | 0.96020678 |
| 106 | * MP0004197_abnormal_fetal_growth/weight/ | 0.95877990 |
| 107 | MP0005385_cardiovascular_system_phenoty | 0.95675583 |
| 108 | MP0001544_abnormal_cardiovascular_syste | 0.95675583 |
| 109 | MP0002254_reproductive_system_inflammat | 0.95429505 |
| 110 | MP0001873_stomach_inflammation | 0.95078624 |
| 111 | * MP0003984_embryonic_growth_retardation | 0.94686032 |
| 112 | MP0003111_abnormal_nucleus_morphology | 0.94250749 |
| 113 | MP0010307_abnormal_tumor_latency | 0.94239661 |
| 114 | MP0005369_muscle_phenotype | 0.94034472 |
| 115 | MP0002166_altered_tumor_susceptibility | 0.92190580 |
| 116 | MP0004215_abnormal_myocardial_fiber | 0.90929610 |
| 117 | * MP0002086_abnormal_extraembryonic_tissu | 0.90509904 |
| 118 | MP0004145_abnormal_muscle_electrophysio | 0.89645965 |
| 119 | MP0008057_abnormal_DNA_replication | 0.89531104 |
| 120 | MP0009333_abnormal_splenocyte_physiolog | 0.89443534 |
| 121 | MP0003866_abnormal_defecation | 0.89269226 |
| 122 | MP0005187_abnormal_penis_morphology | 0.89056883 |
| 123 | MP0004233_abnormal_muscle_weight | 0.87944244 |
| 124 | MP0002277_abnormal_respiratory_mucosa | 0.87568817 |
| 125 | MP0008469_abnormal_protein_level | 0.86785734 |
| 126 | MP0003453_abnormal_keratinocyte_physiol | 0.86410611 |
| 127 | MP0009384_cardiac_valve_regurgitation | 0.86265585 |
| 128 | MP0000537_abnormal_urethra_morphology | 0.85644347 |
| 129 | * MP0000598_abnormal_liver_morphology | 0.85420727 |
| 130 | MP0002084_abnormal_developmental_patter | 0.85205855 |
| 131 | * MP0000266_abnormal_heart_morphology | 0.85032674 |
| 132 | MP0002998_abnormal_bone_remodeling | 0.84705906 |
| 133 | MP0009053_abnormal_anal_canal | 0.83918577 |
| 134 | * MP0001697_abnormal_embryo_size | 0.83233860 |
| 135 | MP0005319_abnormal_enzyme/_coenzyme | 0.83053378 |
| 136 | * MP0002085_abnormal_embryonic_tissue | 0.82499185 |
| 137 | MP0004947_skin_inflammation | 0.82430073 |
| 138 | MP0008875_abnormal_xenobiotic_pharmacok | 0.82183415 |
| 139 | * MP0002925_abnormal_cardiovascular_devel | 0.81494361 |
| 140 | MP0002118_abnormal_lipid_homeostasis | 0.80858630 |
| 141 | MP0008775_abnormal_heart_ventricle | 0.80747917 |
| 142 | * MP0000350_abnormal_cell_proliferation | 0.80437005 |
| 143 | MP0005310_abnormal_salivary_gland | 0.79867985 |
| 144 | MP0005408_hypopigmentation | 0.79582757 |
| 145 | MP0003091_abnormal_cell_migration | 0.78732295 |
| 146 | MP0003115_abnormal_respiratory_system | 0.76743652 |
| 147 | MP0002332_abnormal_exercise_endurance | 0.76298028 |
| 148 | MP0009764_decreased_sensitivity_to | 0.76198707 |
| 149 | MP0003045_fibrosis | 0.75358650 |
| 150 | * MP0005620_abnormal_muscle_contractility | 0.74458697 |
| 151 | MP0001545_abnormal_hematopoietic_system | 0.74387523 |
| 152 | MP0005397_hematopoietic_system_phenotyp | 0.74387523 |
| 153 | * MP0002972_abnormal_cardiac_muscle | 0.73373807 |
| 154 | * MP0002128_abnormal_blood_circulation | 0.72512417 |
| 155 | * MP0002080_prenatal_lethality | 0.72300923 |
| 156 | MP0002148_abnormal_hypersensitivity_rea | 0.72294160 |
| 157 | MP0001958_emphysema | 0.72167778 |
| 158 | MP0000428_abnormal_craniofacial_morphol | 0.71795014 |
| 159 | MP0006138_congestive_heart_failure | 0.70547064 |
| 160 | * MP0001614_abnormal_blood_vessel | 0.70444457 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myositis (HP:0100614) | 4.15906854 |
| 2 | Orchitis (HP:0100796) | 3.93157606 |
| 3 | Deep venous thrombosis (HP:0002625) | 3.68714725 |
| 4 | Retrobulbar optic neuritis (HP:0100654) | 3.64467665 |
| 5 | Optic neuritis (HP:0100653) | 3.64467665 |
| 6 | Gastrointestinal infarctions (HP:0005244) | 3.55420545 |
| 7 | Recurrent fungal infections (HP:0002841) | 3.17245478 |
| 8 | Abnormality of macrophages (HP:0004311) | 3.07802418 |
| 9 | Gingivitis (HP:0000230) | 3.06054391 |
| 10 | Chest pain (HP:0100749) | 3.00872442 |
| 11 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.00820328 |
| 12 | Mediastinal lymphadenopathy (HP:0100721) | 2.99737449 |
| 13 | Cortical dysplasia (HP:0002539) | 2.97218111 |
| 14 | Stomatitis (HP:0010280) | 2.96356835 |
| 15 | Increased IgE level (HP:0003212) | 2.95205076 |
| 16 | Exercise-induced muscle cramps (HP:0003710) | 2.92899031 |
| 17 | Keratoconjunctivitis sicca (HP:0001097) | 2.85867617 |
| 18 | Recurrent cutaneous fungal infections (HP:0011370) | 2.83282894 |
| 19 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.83282894 |
| 20 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.82671070 |
| 21 | Exercise-induced myalgia (HP:0003738) | 2.81745285 |
| 22 | Hypoalphalipoproteinemia (HP:0003233) | 2.75472356 |
| 23 | Xanthomatosis (HP:0000991) | 2.73420799 |
| 24 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.72433248 |
| 25 | Difficulty running (HP:0009046) | 2.71301048 |
| 26 | Recurrent skin infections (HP:0001581) | 2.70530716 |
| 27 | Type 1 muscle fiber predominance (HP:0003803) | 2.70082200 |
| 28 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.70042864 |
| 29 | EMG: myopathic abnormalities (HP:0003458) | 2.68815935 |
| 30 | Spontaneous hematomas (HP:0007420) | 2.67933704 |
| 31 | Cellulitis (HP:0100658) | 2.65211579 |
| 32 | Ventricular tachycardia (HP:0004756) | 2.64895828 |
| 33 | Meningitis (HP:0001287) | 2.62279127 |
| 34 | Right ventricular cardiomyopathy (HP:0011663) | 2.61046740 |
| 35 | Increased connective tissue (HP:0009025) | 2.59583352 |
| 36 | Chronic obstructive pulmonary disease (HP:0006510) | 2.58769990 |
| 37 | Obstructive lung disease (HP:0006536) | 2.58769990 |
| 38 | Increased variability in muscle fiber diameter (HP:0003557) | 2.56566094 |
| 39 | Hypochromic microcytic anemia (HP:0004840) | 2.51387272 |
| 40 | Keratoconjunctivitis (HP:0001096) | 2.51083340 |
| 41 | Inflammation of the large intestine (HP:0002037) | 2.50671961 |
| 42 | Muscle fiber splitting (HP:0003555) | 2.50469487 |
| 43 | Encephalitis (HP:0002383) | 2.50359660 |
| 44 | Gastrointestinal inflammation (HP:0004386) | 2.49406397 |
| 45 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.49330307 |
| 46 | Abnormality of the 4th metacarpal (HP:0010012) | 2.48251010 |
| 47 | Hyporeflexia of lower limbs (HP:0002600) | 2.48127037 |
| 48 | Metaphyseal cupping (HP:0003021) | 2.48057321 |
| 49 | Lymphangioma (HP:0100764) | 2.44740867 |
| 50 | Distal lower limb amyotrophy (HP:0008944) | 2.44291657 |
| 51 | Urticaria (HP:0001025) | 2.40809386 |
| 52 | Abnormality of the fingertips (HP:0001211) | 2.39553150 |
| 53 | Intrahepatic cholestasis (HP:0001406) | 2.37866610 |
| 54 | Pseudobulbar signs (HP:0002200) | 2.37146823 |
| 55 | Fatigue (HP:0012378) | 2.36361163 |
| 56 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 2.35934278 |
| 57 | Short 4th metacarpal (HP:0010044) | 2.35934278 |
| 58 | * Abnormality of the endocardium (HP:0004306) | 2.35148682 |
| 59 | Rhabdomyolysis (HP:0003201) | 2.34793610 |
| 60 | Myoglobinuria (HP:0002913) | 2.33795172 |
| 61 | Complement deficiency (HP:0004431) | 2.33637590 |
| 62 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.32945223 |
| 63 | Muscle fiber inclusion bodies (HP:0100299) | 2.32569354 |
| 64 | Myocardial infarction (HP:0001658) | 2.29784365 |
| 65 | Hyperammonemia (HP:0001987) | 2.28152600 |
| 66 | Arterial thrombosis (HP:0004420) | 2.27946408 |
| 67 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.27127763 |
| 68 | Esophageal varix (HP:0002040) | 2.26883580 |
| 69 | T lymphocytopenia (HP:0005403) | 2.26154322 |
| 70 | Epidermoid cyst (HP:0200040) | 2.24690973 |
| 71 | Ankle contracture (HP:0006466) | 2.21436089 |
| 72 | Ketosis (HP:0001946) | 2.20326928 |
| 73 | Cerebral aneurysm (HP:0004944) | 2.18443698 |
| 74 | Hypochromic anemia (HP:0001931) | 2.17507529 |
| 75 | Hyperlipoproteinemia (HP:0010980) | 2.14201371 |
| 76 | Spastic diplegia (HP:0001264) | 2.13654783 |
| 77 | Sudden death (HP:0001699) | 2.13100286 |
| 78 | Long toe (HP:0010511) | 2.11705796 |
| 79 | Asymmetric septal hypertrophy (HP:0001670) | 2.09180022 |
| 80 | Hypolipoproteinemia (HP:0010981) | 2.09013044 |
| 81 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.07663763 |
| 82 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.07641143 |
| 83 | Subaortic stenosis (HP:0001682) | 2.07641143 |
| 84 | Hyperglycinuria (HP:0003108) | 2.06797108 |
| 85 | Atrioventricular block (HP:0001678) | 2.06470116 |
| 86 | Aortic aneurysm (HP:0004942) | 2.04270301 |
| 87 | Subacute progressive viral hepatitis (HP:0006572) | 2.03537251 |
| 88 | Skin nodule (HP:0200036) | 2.02982846 |
| 89 | Abnormality of the peritoneum (HP:0002585) | 2.02829033 |
| 90 | Heterotopia (HP:0002282) | 2.02692713 |
| 91 | Abnormality of complement system (HP:0005339) | 2.01857376 |
| 92 | Broad metatarsal (HP:0001783) | 2.01397936 |
| 93 | Nemaline bodies (HP:0003798) | 2.00956271 |
| 94 | Hemoptysis (HP:0002105) | 2.00596465 |
| 95 | Slow saccadic eye movements (HP:0000514) | 1.99009063 |
| 96 | Shallow orbits (HP:0000586) | 1.97944975 |
| 97 | Ependymoma (HP:0002888) | 1.97740673 |
| 98 | Ulnar deviation of the wrist (HP:0003049) | 1.97702667 |
| 99 | Recurrent viral infections (HP:0004429) | 1.96889302 |
| 100 | Abnormality of T cell number (HP:0011839) | 1.95819463 |
| 101 | Vasculitis (HP:0002633) | 1.95702576 |
| 102 | Hypoglycemic coma (HP:0001325) | 1.95317801 |
| 103 | Ketoacidosis (HP:0001993) | 1.95224012 |
| 104 | Pelvic girdle muscle weakness (HP:0003749) | 1.93453754 |
| 105 | Granulocytopenia (HP:0001913) | 1.93221113 |
| 106 | Leukocytosis (HP:0001974) | 1.92820956 |
| 107 | Distal lower limb muscle weakness (HP:0009053) | 1.91926130 |
| 108 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.91708326 |
| 109 | Recurrent bacterial skin infections (HP:0005406) | 1.90122240 |
| 110 | Mitral valve prolapse (HP:0001634) | 1.89621031 |
| 111 | Gingival bleeding (HP:0000225) | 1.89366312 |
| 112 | Eczematoid dermatitis (HP:0000976) | 1.85958902 |
| 113 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.83882587 |
| 114 | Ragged-red muscle fibers (HP:0003200) | 1.83765068 |
| 115 | Neck muscle weakness (HP:0000467) | 1.82540977 |
| 116 | Hematochezia (HP:0002573) | 1.81189468 |
| 117 | Difficulty climbing stairs (HP:0003551) | 1.81092750 |
| 118 | Hyperacusis (HP:0010780) | 1.80434043 |
| 119 | Wrist flexion contracture (HP:0001239) | 1.79737576 |
| 120 | Hamartoma of the eye (HP:0010568) | 1.79026725 |
| 121 | Ulnar bowing (HP:0003031) | 1.78312225 |
| 122 | Enlarged penis (HP:0000040) | 1.78144565 |
| 123 | Osteomyelitis (HP:0002754) | 1.77907305 |
| 124 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.77464623 |
| 125 | Back pain (HP:0003418) | 1.77452507 |
| 126 | Frequent falls (HP:0002359) | 1.77434548 |
| 127 | Peritonitis (HP:0002586) | 1.77309749 |
| 128 | EMG: neuropathic changes (HP:0003445) | 1.76481349 |
| 129 | Round ear (HP:0100830) | 1.75913567 |
| 130 | Malignant gastrointestinal tract tumors (HP:0006749) | 1.75788329 |
| 131 | Gastrointestinal carcinoma (HP:0002672) | 1.75788329 |
| 132 | Visceral angiomatosis (HP:0100761) | 1.75473018 |
| 133 | Neonatal death (HP:0003811) | 1.75387301 |
| 134 | Camptodactyly of toe (HP:0001836) | 1.75322607 |
| 135 | Rimmed vacuoles (HP:0003805) | 1.75067788 |
| 136 | Acute hepatic failure (HP:0006554) | 1.72653858 |
| 137 | Recurrent abscess formation (HP:0002722) | 1.72643428 |
| 138 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.72175808 |
| 139 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.72119527 |
| 140 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.72119527 |
| 141 | Polycythemia (HP:0001901) | 1.72083653 |
| 142 | * Aneurysm (HP:0002617) | 1.71888971 |
| 143 | Dysmetric saccades (HP:0000641) | 1.71650959 |
| 144 | Hemangiomatosis (HP:0007461) | 1.70904779 |
| 145 | Abnormality of glycine metabolism (HP:0010895) | 1.70860457 |
| 146 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.70860457 |
| 147 | Hand muscle atrophy (HP:0009130) | 1.70462358 |
| 148 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.70296755 |
| 149 | Anorexia (HP:0002039) | 1.68889463 |
| 150 | * Lipoatrophy (HP:0100578) | 1.68768952 |
| 151 | Toxemia of pregnancy (HP:0100603) | 1.68752606 |
| 152 | Astrocytoma (HP:0009592) | 1.68051735 |
| 153 | Abnormality of the astrocytes (HP:0100707) | 1.68051735 |
| 154 | Multiple enchondromatosis (HP:0005701) | 1.67698770 |
| 155 | Abnormality of the foot musculature (HP:0001436) | 1.67350307 |
| 156 | Fibroma (HP:0010614) | 1.67202568 |
| 157 | Abnormal cartilage morphology (HP:0002763) | 1.66965714 |
| 158 | Myopathic facies (HP:0002058) | 1.66176675 |
| 159 | Abnormality of the calcaneus (HP:0008364) | 1.65927276 |
| 160 | Bowel incontinence (HP:0002607) | 1.65867004 |
| 161 | Colitis (HP:0002583) | 1.65514314 |
| 162 | Increased density of long bones (HP:0006392) | 1.65473371 |
| 163 | Papillary thyroid carcinoma (HP:0002895) | 1.64961817 |
| 164 | Ankle clonus (HP:0011448) | 1.64939782 |
| 165 | Hepatocellular carcinoma (HP:0001402) | 1.63384214 |
| 166 | Sepsis (HP:0100806) | 1.63046122 |
| 167 | Persistence of primary teeth (HP:0006335) | 1.62899214 |
| 168 | Onion bulb formation (HP:0003383) | 1.62099733 |
| 169 | Fibrous tissue neoplasm (HP:0012316) | 1.62000304 |
| 170 | Viral hepatitis (HP:0006562) | 1.60560839 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 4.20557754 |
| 2 | PKN2 | 3.71012358 |
| 3 | EEF2K | 3.43785460 |
| 4 | TTN | 3.23355991 |
| 5 | LATS1 | 3.08946001 |
| 6 | PRPF4B | 3.07659432 |
| 7 | RIPK4 | 2.89624848 |
| 8 | MAP3K10 | 2.70231365 |
| 9 | IRAK4 | 2.54170771 |
| 10 | BLK | 2.31757259 |
| 11 | LATS2 | 2.15514117 |
| 12 | SIK1 | 2.10209918 |
| 13 | EPHA3 | 1.97182611 |
| 14 | TAOK1 | 1.95375896 |
| 15 | NEK2 | 1.91600420 |
| 16 | ERN1 | 1.69775647 |
| 17 | PDGFRA | 1.66423727 |
| 18 | CDK12 | 1.63762207 |
| 19 | STK38L | 1.63070619 |
| 20 | FGFR4 | 1.61928365 |
| 21 | SIK3 | 1.61736664 |
| 22 | ZAP70 | 1.61276115 |
| 23 | PTK6 | 1.60469158 |
| 24 | TNK2 | 1.47759949 |
| 25 | RIPK1 | 1.47325704 |
| 26 | STK10 | 1.46273810 |
| 27 | BRD4 | 1.46030345 |
| 28 | MAP2K3 | 1.45075598 |
| 29 | STK3 | 1.42379276 |
| 30 | FES | 1.42027478 |
| 31 | SMG1 | 1.42000292 |
| 32 | ERBB4 | 1.41869914 |
| 33 | CAMK1D | 1.39055110 |
| 34 | MAPKAPK3 | 1.34419163 |
| 35 | MAP2K4 | 1.32744933 |
| 36 | BCKDK | 1.28444145 |
| 37 | * HCK | 1.27790453 |
| 38 | RPS6KB2 | 1.27686043 |
| 39 | SGK3 | 1.26848031 |
| 40 | FGR | 1.24523030 |
| 41 | TYK2 | 1.23557139 |
| 42 | IRAK1 | 1.21714861 |
| 43 | BTK | 1.20988453 |
| 44 | DMPK | 1.20078962 |
| 45 | MAP3K14 | 1.17965481 |
| 46 | MELK | 1.14931115 |
| 47 | ACVR1B | 1.14803816 |
| 48 | IKBKE | 1.14746738 |
| 49 | YES1 | 1.09396816 |
| 50 | MAP3K1 | 1.08048381 |
| 51 | PHKG2 | 1.05598662 |
| 52 | PHKG1 | 1.05598662 |
| 53 | TYRO3 | 1.04345301 |
| 54 | IRAK2 | 1.04205694 |
| 55 | MTOR | 1.03833410 |
| 56 | SGK2 | 1.02355976 |
| 57 | LRRK2 | 1.01696595 |
| 58 | CDK4 | 1.01016483 |
| 59 | CDK9 | 0.96074456 |
| 60 | RPS6KA4 | 0.95761895 |
| 61 | MARK3 | 0.95362586 |
| 62 | FLT3 | 0.93058395 |
| 63 | MAP3K6 | 0.92757421 |
| 64 | CDC7 | 0.91880916 |
| 65 | CDK6 | 0.91858544 |
| 66 | MAPK11 | 0.91812796 |
| 67 | PIK3CG | 0.90901862 |
| 68 | TESK2 | 0.90640216 |
| 69 | MAP3K8 | 0.90240509 |
| 70 | MAP3K7 | 0.89398530 |
| 71 | MAP3K2 | 0.89346450 |
| 72 | NEK1 | 0.87698747 |
| 73 | TTK | 0.87630487 |
| 74 | OBSCN | 0.87555969 |
| 75 | CAMK1G | 0.86717803 |
| 76 | MAP4K1 | 0.86244031 |
| 77 | ITK | 0.84551459 |
| 78 | SYK | 0.83670393 |
| 79 | TBK1 | 0.82742208 |
| 80 | JAK3 | 0.81260695 |
| 81 | RPS6KC1 | 0.77594670 |
| 82 | RPS6KL1 | 0.77594670 |
| 83 | TRPM7 | 0.77327264 |
| 84 | PDGFRB | 0.77141306 |
| 85 | SIK2 | 0.77047048 |
| 86 | HIPK2 | 0.74996781 |
| 87 | CAMK4 | 0.74660448 |
| 88 | TXK | 0.73388182 |
| 89 | MAP3K3 | 0.70522744 |
| 90 | PAK4 | 0.69907822 |
| 91 | ICK | 0.69756814 |
| 92 | STK4 | 0.69326241 |
| 93 | EPHB1 | 0.67369551 |
| 94 | * LYN | 0.65595530 |
| 95 | * PRKAA1 | 0.65031657 |
| 96 | RPS6KA6 | 0.64712667 |
| 97 | LCK | 0.63915136 |
| 98 | SGK494 | 0.63277365 |
| 99 | SGK223 | 0.63277365 |
| 100 | LMTK2 | 0.61643930 |
| 101 | CSK | 0.60587454 |
| 102 | ERBB2 | 0.60051317 |
| 103 | TAOK3 | 0.58870750 |
| 104 | CSF1R | 0.58738009 |
| 105 | * PRKAA2 | 0.58648816 |
| 106 | PDPK1 | 0.58573583 |
| 107 | * KSR2 | 0.58375746 |
| 108 | RET | 0.58170500 |
| 109 | STK38 | 0.58134627 |
| 110 | PDK1 | 0.57826918 |
| 111 | MAPK7 | 0.57605188 |
| 112 | PTK2 | 0.57589292 |
| 113 | JAK1 | 0.57024291 |
| 114 | FGFR3 | 0.56268444 |
| 115 | CDK19 | 0.55977100 |
| 116 | RPS6KA2 | 0.55273054 |
| 117 | DYRK3 | 0.54613979 |
| 118 | NEK9 | 0.54376535 |
| 119 | MAPK12 | 0.52483236 |
| 120 | PIM1 | 0.52099342 |
| 121 | DYRK1B | 0.51848221 |
| 122 | MAP2K7 | 0.51289695 |
| 123 | MAP3K9 | 0.51034209 |
| 124 | MAP3K13 | 0.48454594 |
| 125 | MAP3K5 | 0.47566274 |
| 126 | CHEK2 | 0.46557565 |
| 127 | PAK2 | 0.46183552 |
| 128 | ALK | 0.45920974 |
| 129 | STK24 | 0.45596746 |
| 130 | NLK | 0.44779343 |
| 131 | FGFR2 | 0.44733775 |
| 132 | TAOK2 | 0.44512149 |
| 133 | ILK | 0.44490550 |
| 134 | * JAK2 | 0.44168576 |
| 135 | CHUK | 0.43675514 |
| 136 | RPS6KA1 | 0.43362560 |
| 137 | DDR2 | 0.43087820 |
| 138 | PRKD1 | 0.42330010 |
| 139 | MAP2K2 | 0.42086442 |
| 140 | CLK1 | 0.42024163 |
| 141 | TGFBR1 | 0.41912373 |
| 142 | CDC42BPA | 0.41628848 |
| 143 | FGFR1 | 0.40616757 |
| 144 | AKT2 | 0.39947859 |
| 145 | GRK6 | 0.39911013 |
| 146 | WNK1 | 0.38705681 |
| 147 | MARK2 | 0.38491805 |
| 148 | MAP3K11 | 0.37230712 |
| 149 | PRKD2 | 0.36297707 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.75647185 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.63051562 |
| 3 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.33707078 |
| 4 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.32307483 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.21708555 |
| 6 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.15931669 |
| 7 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.00306855 |
| 8 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.99494961 |
| 9 | Lysine degradation_Homo sapiens_hsa00310 | 1.96757919 |
| 10 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.95090996 |
| 11 | * Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.79510526 |
| 12 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.76659605 |
| 13 | Measles_Homo sapiens_hsa05162 | 1.75850530 |
| 14 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.75307620 |
| 15 | * Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.71516990 |
| 16 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.66251996 |
| 17 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.60205208 |
| 18 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.58888438 |
| 19 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.58527416 |
| 20 | * T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.57311162 |
| 21 | * Tuberculosis_Homo sapiens_hsa05152 | 1.56972969 |
| 22 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.55782341 |
| 23 | Insulin resistance_Homo sapiens_hsa04931 | 1.46550296 |
| 24 | Viral myocarditis_Homo sapiens_hsa05416 | 1.45262921 |
| 25 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.44163243 |
| 26 | * Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.44073125 |
| 27 | * Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.41079562 |
| 28 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.35101737 |
| 29 | Carbon metabolism_Homo sapiens_hsa01200 | 1.34517180 |
| 30 | * Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.34353165 |
| 31 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.34326766 |
| 32 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.34197275 |
| 33 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.31669764 |
| 34 | * Influenza A_Homo sapiens_hsa05164 | 1.28189365 |
| 35 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.24026333 |
| 36 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.21644751 |
| 37 | Shigellosis_Homo sapiens_hsa05131 | 1.19615784 |
| 38 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.17165124 |
| 39 | * Hepatitis C_Homo sapiens_hsa05160 | 1.16712029 |
| 40 | * Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.16478519 |
| 41 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.13386989 |
| 42 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.13070589 |
| 43 | Malaria_Homo sapiens_hsa05144 | 1.11585001 |
| 44 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.11070958 |
| 45 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.10756655 |
| 46 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.08629833 |
| 47 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.08585307 |
| 48 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.07393873 |
| 49 | * Pancreatic cancer_Homo sapiens_hsa05212 | 1.05711297 |
| 50 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.05280850 |
| 51 | Adherens junction_Homo sapiens_hsa04520 | 1.05178490 |
| 52 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.05143966 |
| 53 | * Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.05080566 |
| 54 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.02165720 |
| 55 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.01889093 |
| 56 | * ErbB signaling pathway_Homo sapiens_hsa04012 | 1.01023093 |
| 57 | Thyroid cancer_Homo sapiens_hsa05216 | 1.00387525 |
| 58 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.98065666 |
| 59 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.97262465 |
| 60 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.96979981 |
| 61 | * MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.96315633 |
| 62 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.96253383 |
| 63 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.95491121 |
| 64 | Platelet activation_Homo sapiens_hsa04611 | 0.93352161 |
| 65 | * Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.91850207 |
| 66 | Cell cycle_Homo sapiens_hsa04110 | 0.91126434 |
| 67 | Phagosome_Homo sapiens_hsa04145 | 0.89341889 |
| 68 | Salmonella infection_Homo sapiens_hsa05132 | 0.88308159 |
| 69 | * GnRH signaling pathway_Homo sapiens_hsa04912 | 0.87278574 |
| 70 | Leishmaniasis_Homo sapiens_hsa05140 | 0.86196867 |
| 71 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.84970223 |
| 72 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.84626876 |
| 73 | * Prostate cancer_Homo sapiens_hsa05215 | 0.82786522 |
| 74 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.80986559 |
| 75 | Endocytosis_Homo sapiens_hsa04144 | 0.80670949 |
| 76 | * Insulin signaling pathway_Homo sapiens_hsa04910 | 0.80350273 |
| 77 | * Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.79181722 |
| 78 | Peroxisome_Homo sapiens_hsa04146 | 0.78217897 |
| 79 | * Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.77699769 |
| 80 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.77599318 |
| 81 | * Glioma_Homo sapiens_hsa05214 | 0.77204981 |
| 82 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.76771029 |
| 83 | * Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.76688059 |
| 84 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.76368342 |
| 85 | Sulfur relay system_Homo sapiens_hsa04122 | 0.75772505 |
| 86 | * Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.75628123 |
| 87 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.75295264 |
| 88 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.75177736 |
| 89 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.74893458 |
| 90 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.74339384 |
| 91 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.73829197 |
| 92 | * Colorectal cancer_Homo sapiens_hsa05210 | 0.73663672 |
| 93 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.72749778 |
| 94 | * Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.72266003 |
| 95 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.72206139 |
| 96 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.72088080 |
| 97 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.71907568 |
| 98 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.71439634 |
| 99 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.70587061 |
| 100 | * Focal adhesion_Homo sapiens_hsa04510 | 0.69462847 |
| 101 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.68948613 |
| 102 | Bile secretion_Homo sapiens_hsa04976 | 0.68396224 |
| 103 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.68025891 |
| 104 | * Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.67889279 |
| 105 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.67708273 |
| 106 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.67451656 |
| 107 | Other glycan degradation_Homo sapiens_hsa00511 | 0.66796255 |
| 108 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.66510834 |
| 109 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.66396750 |
| 110 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.66230770 |
| 111 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.64405904 |
| 112 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.64405565 |
| 113 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.63506363 |
| 114 | * VEGF signaling pathway_Homo sapiens_hsa04370 | 0.63213497 |
| 115 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.62767574 |
| 116 | Histidine metabolism_Homo sapiens_hsa00340 | 0.62716553 |
| 117 | * B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.62485429 |
| 118 | * MAPK signaling pathway_Homo sapiens_hsa04010 | 0.62209493 |
| 119 | Amoebiasis_Homo sapiens_hsa05146 | 0.61958499 |
| 120 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.61730268 |
| 121 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.61676227 |
| 122 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.61636805 |
| 123 | Circadian rhythm_Homo sapiens_hsa04710 | 0.60415905 |
| 124 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.59843810 |
| 125 | Pertussis_Homo sapiens_hsa05133 | 0.59470237 |
| 126 | * Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.58538375 |
| 127 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.57512282 |
| 128 | * Endometrial cancer_Homo sapiens_hsa05213 | 0.57499904 |
| 129 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.56914384 |
| 130 | HTLV-I infection_Homo sapiens_hsa05166 | 0.56294157 |
| 131 | * Renal cell carcinoma_Homo sapiens_hsa05211 | 0.56265925 |
| 132 | * FoxO signaling pathway_Homo sapiens_hsa04068 | 0.56264192 |
| 133 | * Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.55083080 |
| 134 | * Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.54464632 |
| 135 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.53847548 |
| 136 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.53656902 |
| 137 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.53358363 |
| 138 | Legionellosis_Homo sapiens_hsa05134 | 0.53254006 |
| 139 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.52833045 |
| 140 | Allograft rejection_Homo sapiens_hsa05330 | 0.52632947 |
| 141 | * Bladder cancer_Homo sapiens_hsa05219 | 0.51862522 |
| 142 | * Hepatitis B_Homo sapiens_hsa05161 | 0.51713251 |
| 143 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.50906416 |
| 144 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.50493183 |
| 145 | * Apoptosis_Homo sapiens_hsa04210 | 0.50054385 |
| 146 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.50025054 |
| 147 | * Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.49851843 |
| 148 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.49033933 |
| 149 | * Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.48990903 |
| 150 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.48728076 |
| 151 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.48615232 |
| 152 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.48526313 |
| 153 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.47835587 |
| 154 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.47247522 |
| 155 | Retinol metabolism_Homo sapiens_hsa00830 | 0.45012162 |
| 156 | * Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.43092547 |

